Clinical Trial Update: A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

A Phase I clinical study of a new oral pentamidine formulation in hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Pentamidine (pentamidine)

Snippet

Sponsor: Oncozyme Pharma Inc. | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED